Preoperative SARS-CoV-2 Infection Screening before Thoracic Surgery during COVID-19 Pandemic: A Multicenter Retrospective Study

Table 2

Clinical characteristics of patients undergoing preoperative screening.

Characteristics	Anamnestic questionnaire (N = 275)	Combined anamnestic questionnaire and SARS-CoV-2 RT-PCR (N = 77)	Combined anamnestic questionnaire and chest CT scan (N = 78)
Age (years ± SD)	63.22 ± 13.26	64.66 ± 13.42	61.84 ± 13.60
Sex (M/F)	163/112	52/25	40/38
Hypertension (yes/no)	128/147	48/29	26/51
Diabetes mellitus (yes/no)	28/247	11/66	3/75
CAD (yes/no)	20/255	13/64	6/72
COPD (yes/no)	104/175	19/58	10/68
ASA II/III	120/155	34/44	58/20
Thoracic surgery center
SAND	138	68	0
ITM	78	9	78
MON	59	0	0
Scheduled surgery
Lung resection open	89	43	32
Lung resection VATS	122	11	29
VATS/pleural biopsy	23	6	8
Mediastinoscopy	16	7	4
Mediastinotomy	10	4	3
Tracheal surgery	5	5	0
Chest wall resection	3	0	2
Rigid bronchoscopy	7	2	0

The data are expressed as the mean and SD or N° of patients. Abbreviations: ASA, American Society of Anesthesiologists; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; F, female; CT, computed tomography; ITM, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; M, male; MON, A.O. dei Colli, Ospedale Monaldi, Napoli, Italy; RT–PCR, reverse transcriptase polymerase chain reaction; SAND, Sant’Andrea Hospital, University of Rome “Sapienza”, Rome, Italy; SD, standard deviation; and VATS, video-assisted thoracoscopic surgery.